Inhibition of Arachidonate-Induced Human Platelet Aggregation by a Single Low Oral Dose of Aspirin in Combination with a Thromboxane Synthase Inhibitor

• References

• 1 Bertelé V, Cerletti C, Schieppati A, Di Minno G, de Gaetano G. Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation. Lancet 1981; 1: 1057-1058
• 2 Heptinstall S, Bevan J, Cockbill SR, Hanley SP, Parry MJ. Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thromb Res 1980; 80: 219-230
• 3 Bertelé V, Falanga A, Tomasiak M, Dejana E, Cerletti C, de Gaetano G. Platelet thromboxane synthetase inhibitors with low doses of aspirin: Possible resolution of the »aspirin dilemma«. Science 1983; 220: 517-519
• 4 Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982; 69: 1366-1372
• 5 Editorial. Dazoxiben. Lancet 1983; 1: 627-628
• 6 Di Minno G, Silver MJ, de Gaetano G. Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol 1979; 43: 637-647
• 7 Jones EW, Cockbill SR, Cowley AJ, Hanley SP, Heptinstall S. Effects of dazoxiben and low-dose aspirin on platelet behaviour in man. Br J Clin Pharmacol 1983; 15: 39-44